Go to course page

Use of SGRT in SBRT: Can We Possibly Reduce Margin Expansion and Treatment-Related Toxicity?

Dr J Heinzerling, MD, Southeast Radiation Oncology Group, USA

 

Go to previous session Go to next session

Further reading and information:

• Click here for the original & unedited presentation